If you have transferred good-looking embryos two or three times and none have led to a pregnancy, it is natural to feel that something must be wrong with you. Almost always, it is not about effort or willpower — this is biology, and biology can usually be examined. This article explains what recurrent IVF failure actually means, the main reasons it happens, and what a careful re-evaluation looks like before you try again.
What counts as recurrent IVF failure?
There is no single universally agreed definition, but most clinicians use a practical one: the failure of two or three embryo transfers to result in a pregnancy, when good-quality embryos were transferred. The emphasis on good-quality embryos matters. A single failed cycle, or a cycle where the embryos were fragile or few, is disappointing but not unusual — implantation is an inefficient process even in nature. It is the repeated failure of embryos that looked genuinely promising that prompts a deeper look.
Two honest truths sit alongside each other here. First, even in the best circumstances a proportion of transfers will not implant, so some repeated failure is down to chance. Second, once you cross the two-to-three-transfer line, it becomes reasonable to pause and investigate rather than simply repeat the same cycle a fourth time. Knowing when to look harder — and when a difference is just statistical noise — is a large part of the art.
The main causes, and how strong the evidence is
Causes of recurrent failure fall into a few broad groups. Being honest about how well each is supported by evidence is important, because a great deal of unproven testing and treatment is marketed to couples at this vulnerable stage.
Embryo and chromosomal factors (strong evidence)
The single most common reason a normal-looking embryo fails to implant is that it carries the wrong number of chromosomes (aneuploidy). An embryo can look perfect under the microscope and still be genetically unable to develop. The likelihood of aneuploidy rises steeply with the age of the egg, which is why age is such a powerful factor in IVF success rates. This is the best-established cause of repeated failure, and it explains why embryo appearance alone is an imperfect guide.
Uterine and structural factors (strong evidence)
The cavity that receives the embryo has to be healthy. Fibroids that distort the cavity, polyps, scar tissue (adhesions), or an untreated hydrosalpinx (a fluid-filled, blocked tube) can all reduce implantation, and correcting them is well supported. These are among the most worthwhile things to check because they are treatable and the benefit of treating them is real.
Endometrial receptivity and timing (moderate, evolving evidence)
The lining of the womb is only receptive to an embryo during a short window. In most people that window is where we expect it to be, but in a minority it may be shifted. Tests that aim to personalise transfer timing exist and can help selected patients — you can read more in our article on the ERA test and implantation — but the evidence that they improve outcomes for everyone is mixed, and they are not a routine first step for most people.
Immune and thrombophilia factors (weak or contested evidence)
This is the area where the gap between marketing and evidence is widest. A great many immune tests and treatments — intralipids, steroids, blood thinners, natural-killer-cell testing — are offered for recurrent failure. For most patients, the evidence that these help is weak or absent, and some carry real risks. There are specific, well-defined conditions (such as antiphospholipid syndrome) that genuinely warrant treatment, but these are diagnosed with recognised criteria, not with broad immune panels. A good clinic will be candid about what is proven and what is speculative.
What a structured re-evaluation looks like
Rather than reaching for the next add-on, a careful re-evaluation works methodically through the treatable and well-evidenced causes first. In practice this usually means reviewing:
- The embryos themselves — their quality, the stage at transfer, and whether genetic testing of embryos might clarify why chromosomally they are failing, particularly where egg age is a factor.
- The uterine cavity — typically with a hysteroscopy or a high-quality scan to rule out polyps, fibroids distorting the cavity, adhesions or a hydrosalpinx.
- The stimulation and laboratory approach — whether the protocol suited your ovarian reserve and response, and whether a frozen transfer into a more natural hormonal environment might suit you better than a fresh one.
- The basics — thyroid function, vitamin D, blood sugar, weight, smoking, and other health factors that quietly influence implantation.
- Selective further testing — receptivity or specific clotting/immune tests only where the history genuinely points to them, not as a blanket panel.
The aim is to find a reason, or to reassure you that the treatable reasons have been excluded, before committing to another cycle. ESHRE guidance repeatedly stresses evidence-based, individualised care over unproven add-ons at this stage.
Changing the protocol versus investigating further
A common question is whether the next step should be a new drug protocol or more tests. The honest answer depends on what the first cycles showed. If your embryos were consistently good and the cavity is healthy, simply repeating with a tweaked protocol may be reasonable — sometimes success is a matter of the right embryo meeting the right cycle. If embryos were few or fragile, the conversation may shift towards egg and sperm quality, including a thorough look at the male side, which contributes to roughly half of fertility difficulties. If the pattern suggests a cavity or receptivity issue, targeted investigation comes first.
One honest note for international patients: egg, sperm and embryo donation are not permitted in Turkey. Our clinic provides IVF and ICSI using your own eggs and sperm, and where the history suggests that own-gamete treatment is unlikely to succeed, the physician will tell you that honestly rather than encourage repeated cycles with little realistic chance. That candour is part of good care.
The emotional toll is real
Repeated failure is exhausting in a way that is hard to convey to anyone who has not lived it. Grief, self-blame, strain on relationships, and the dread of another two-week wait are normal responses, not signs of weakness. It helps to name this openly with your team, to take planned breaks when you need them, and to seek support — counselling, peer groups, or simply a doctor who will sit with the uncertainty alongside you. A repeated failure is information about biology; it is not a verdict on you.
If you would like to understand the wider picture first, our complete guide to IVF and the IVF overview are good starting points. When you are ready, a calm, structured review with an experienced team — guided by ESHRE and HFEA evidence rather than by hope alone — is usually the most useful next step.
Sources: ESHRE, HFEA, WHO and accepted reproductive-medicine guidance. This article is for general education and does not replace a medical consultation. Reviewed by Assist. Prof. Dr. Muzaffer Uçarer (Obstetrics & Gynaecology · IVF and Reproductive Medicine), UCARER Women’s Health, Istanbul.
